BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study

John Munkhaugen, Vidar Ruddox, Sigrun Halvorsen, Toril Dammen, Morten W Fagerland, Kjersti H Hernæs, Nils Tore Vethe, Eva Prescott, Svend Eggert Jensen, Olaf Rødevand, Jarle Jortveit, Bjørn Bendz, Henrik Schirmer, Lars Køber, Hans Erik Bøtker, Alf Inge Larsen, Kjell Vikenes, Terje Steigen, Rune Wiseth, Terje PedersenThor Edvardsen, Jan Erik Otterstad, Dan Atar

Research output: Contribution to journalJournal articleResearchpeer-review

3 Citations (Scopus)
2 Downloads (Pure)
Original languageEnglish
JournalAmerican Heart Journal
Volume208
Pages (from-to)37-46
Number of pages10
ISSN0002-8703
DOIs
Publication statusPublished - 1 Feb 2019

Fingerprint

Stroke Volume
Myocardial Infarction
Heart Failure
Mortality
Therapeutics
Registries
Hospital Records
Percutaneous Coronary Intervention
Random Allocation
Secondary Prevention
Multicenter Studies
Reperfusion
Medical Records
Cardiac Arrhythmias
Hospitalization
Guidelines
Psychology
Safety
Drug Therapy
Health

Cite this

Munkhaugen, John ; Ruddox, Vidar ; Halvorsen, Sigrun ; Dammen, Toril ; Fagerland, Morten W ; Hernæs, Kjersti H ; Vethe, Nils Tore ; Prescott, Eva ; Jensen, Svend Eggert ; Rødevand, Olaf ; Jortveit, Jarle ; Bendz, Bjørn ; Schirmer, Henrik ; Køber, Lars ; Bøtker, Hans Erik ; Larsen, Alf Inge ; Vikenes, Kjell ; Steigen, Terje ; Wiseth, Rune ; Pedersen, Terje ; Edvardsen, Thor ; Otterstad, Jan Erik ; Atar, Dan. / BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI) : Rationale and design of a prospective, randomized, open, blinded end point study. In: American Heart Journal. 2019 ; Vol. 208. pp. 37-46.
@article{be70513e9e8144b3895778e83d0904a2,
title = "BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study",
author = "John Munkhaugen and Vidar Ruddox and Sigrun Halvorsen and Toril Dammen and Fagerland, {Morten W} and Hern{\ae}s, {Kjersti H} and Vethe, {Nils Tore} and Eva Prescott and Jensen, {Svend Eggert} and Olaf R{\o}devand and Jarle Jortveit and Bj{\o}rn Bendz and Henrik Schirmer and Lars K{\o}ber and B{\o}tker, {Hans Erik} and Larsen, {Alf Inge} and Kjell Vikenes and Terje Steigen and Rune Wiseth and Terje Pedersen and Thor Edvardsen and Otterstad, {Jan Erik} and Dan Atar",
note = "Copyright {\circledC} 2018 Elsevier Inc. All rights reserved.",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/j.ahj.2018.10.005",
language = "English",
volume = "208",
pages = "37--46",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby, Inc.",

}

Munkhaugen, J, Ruddox, V, Halvorsen, S, Dammen, T, Fagerland, MW, Hernæs, KH, Vethe, NT, Prescott, E, Jensen, SE, Rødevand, O, Jortveit, J, Bendz, B, Schirmer, H, Køber, L, Bøtker, HE, Larsen, AI, Vikenes, K, Steigen, T, Wiseth, R, Pedersen, T, Edvardsen, T, Otterstad, JE & Atar, D 2019, 'BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study', American Heart Journal, vol. 208, pp. 37-46. https://doi.org/10.1016/j.ahj.2018.10.005

BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI) : Rationale and design of a prospective, randomized, open, blinded end point study. / Munkhaugen, John; Ruddox, Vidar; Halvorsen, Sigrun; Dammen, Toril; Fagerland, Morten W; Hernæs, Kjersti H; Vethe, Nils Tore; Prescott, Eva; Jensen, Svend Eggert; Rødevand, Olaf; Jortveit, Jarle; Bendz, Bjørn; Schirmer, Henrik; Køber, Lars; Bøtker, Hans Erik; Larsen, Alf Inge; Vikenes, Kjell; Steigen, Terje; Wiseth, Rune; Pedersen, Terje; Edvardsen, Thor; Otterstad, Jan Erik; Atar, Dan.

In: American Heart Journal, Vol. 208, 01.02.2019, p. 37-46.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI)

T2 - Rationale and design of a prospective, randomized, open, blinded end point study

AU - Munkhaugen, John

AU - Ruddox, Vidar

AU - Halvorsen, Sigrun

AU - Dammen, Toril

AU - Fagerland, Morten W

AU - Hernæs, Kjersti H

AU - Vethe, Nils Tore

AU - Prescott, Eva

AU - Jensen, Svend Eggert

AU - Rødevand, Olaf

AU - Jortveit, Jarle

AU - Bendz, Bjørn

AU - Schirmer, Henrik

AU - Køber, Lars

AU - Bøtker, Hans Erik

AU - Larsen, Alf Inge

AU - Vikenes, Kjell

AU - Steigen, Terje

AU - Wiseth, Rune

AU - Pedersen, Terje

AU - Edvardsen, Thor

AU - Otterstad, Jan Erik

AU - Atar, Dan

N1 - Copyright © 2018 Elsevier Inc. All rights reserved.

PY - 2019/2/1

Y1 - 2019/2/1

UR - http://www.scopus.com/inward/record.url?scp=85057808059&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2018.10.005

DO - 10.1016/j.ahj.2018.10.005

M3 - Journal article

C2 - 30530121

VL - 208

SP - 37

EP - 46

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

ER -